AU2003212348A1 - Hepatitis c virus replicon containing a reporter gene and a selectable marker gene - Google Patents

Hepatitis c virus replicon containing a reporter gene and a selectable marker gene

Info

Publication number
AU2003212348A1
AU2003212348A1 AU2003212348A AU2003212348A AU2003212348A1 AU 2003212348 A1 AU2003212348 A1 AU 2003212348A1 AU 2003212348 A AU2003212348 A AU 2003212348A AU 2003212348 A AU2003212348 A AU 2003212348A AU 2003212348 A1 AU2003212348 A1 AU 2003212348A1
Authority
AU
Australia
Prior art keywords
hepatitis
selectable marker
gene
virus replicon
replicon containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003212348A
Other versions
AU2003212348A8 (en
Inventor
Mylene Caussette
Veronique Ferreol
Brigitte Lindet
Gabriel Marinus Henricus Meesters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of AU2003212348A1 publication Critical patent/AU2003212348A1/en
Publication of AU2003212348A8 publication Critical patent/AU2003212348A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2003212348A 2002-03-12 2003-03-07 Hepatitis c virus replicon containing a reporter gene and a selectable marker gene Abandoned AU2003212348A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02076340.5 2002-03-12
EP02076340 2002-03-12
PCT/EP2003/002603 WO2003076456A2 (en) 2002-03-12 2003-03-07 Hepatitis c virus replicon containing a reporter gene and a selectable marker gene

Publications (2)

Publication Number Publication Date
AU2003212348A1 true AU2003212348A1 (en) 2003-09-22
AU2003212348A8 AU2003212348A8 (en) 2003-09-22

Family

ID=27798892

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003212348A Abandoned AU2003212348A1 (en) 2002-03-12 2003-03-07 Hepatitis c virus replicon containing a reporter gene and a selectable marker gene

Country Status (2)

Country Link
AU (1) AU2003212348A1 (en)
WO (1) WO2003076456A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1025723C2 (en) 2004-03-15 2005-09-16 Univ Delft Tech Method for the preparation of a protein aggregate and a pharmaceutical preparation.
WO2008065138A1 (en) * 2006-11-29 2008-06-05 Novo Nordisk A/S Novel insulin crystal and method for preparing the crystal
FR3006055B1 (en) 2013-05-24 2020-08-14 Commissariat Energie Atomique PROCESS FOR CHARACTERIZING BY TANDEM MASS SPECTROMETRY A BIOLOGICAL SAMPLE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523231A (en) * 1990-02-13 1996-06-04 Amersham International Plc Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules
EP0796335A1 (en) * 1994-12-07 1997-09-24 Bionebraska, Inc. Production of peptides using recombinant fusion protein constructs
US20030048341A1 (en) * 2000-09-25 2003-03-13 Mutz Mitchell W. High-throughput biomolecular crystallization and biomolecular crystal screening

Also Published As

Publication number Publication date
WO2003076456A3 (en) 2003-12-24
AU2003212348A8 (en) 2003-09-22
WO2003076456A2 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
AU2003302409A1 (en) Bioinformatically detectable group of novel viral regulatory genes and uses thereof
AU2003259155A1 (en) Pharmaceutical compositions comprising hepatitis c viral protease inhibitors
SI1414797T1 (en) Hepatitis c virus polymerase inhibitors with a heterobicylic structure
PL373411A1 (en) Hepatitis c virus inhibitors
AU2003215806A1 (en) Disinfectant with activity against hepatitis b virus
AU2003206862A1 (en) Hepatitis b vaccines
AU2003232004A1 (en) Chimeric ebola virus envelopes and uses therefor
EP1485488A4 (en) Recombinant negative strand virus rna expression systems and vaccines
AU2003212348A1 (en) Hepatitis c virus replicon containing a reporter gene and a selectable marker gene
EP1368058A4 (en) Viral reporter particles
AU2003297396A1 (en) Improved aln material and electrostatic chuck incorporating same
AU2002258387A1 (en) Rat toxicologically relevant genes and uses thereof
AU2002368225A1 (en) Viral interferon antagonists and uses therefor
AU2003264783A1 (en) Multi-med-uses retractable non-reusable syringe
AUPS271902A0 (en) Gene expression and multiple sclerosis
AU2003230790A1 (en) Hepatitis c virus sub-genomic replicons
AU2002310969A1 (en) Reporter virus comprising heterologous envelope proteins
AU2003240752A1 (en) Field electron emission materials and devices
AU2003293807A1 (en) Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
AU2003248723A8 (en) Compositions and methods for viral resistance genes
AU2003273035A1 (en) Gene vaccine
AU2003256404A1 (en) Hepatitis c virus assays
AU2003289016A1 (en) Method of distinguishing drug-resistance of hepatitis b virus
AU2003263246A1 (en) Novel acetylcholinesterase gene responsible for insecticide resistance and applications thereof
AU2003902983A0 (en) Viral polymerase and modulation thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase